Cart
sales@molnova.com
JNJ-40355003
CAS No. 1394894-41-7
JNJ-40355003( —— )
Catalog No. M34296 CAS No. 1394894-41-7
JNJ-40355003 is a specific fatty acid amide hydrolase (FAAH) inhibitor that increases plasma levels of fatty acid amides in rats, dogs, and crabs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJNJ-40355003
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-40355003 is a specific fatty acid amide hydrolase (FAAH) inhibitor that increases plasma levels of fatty acid amides in rats, dogs, and crabs.
-
DescriptionJNJ-40355003 is a potent and selective atty acid amide hydrolase (FAAH) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFAAH
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1394894-41-7
-
Formula Weight422.91
-
Molecular FormulaC23H23ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C=NC=CC1)N2CCN(CC=3C=CC=C(OC4=CC=C(Cl)C=C4)C3)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. John M Keith, et al. Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. ACS Med Chem Lett. 2012 Aug 22;3(10):823-7.?
molnova catalog
related products
-
URB-597
A potent and selective FAAH inhibitor with IC50 of 4.6 nM; increases anandamide levels in the brain of rats and wild-type mice (0.3 mg/kg i.p.); improves cognitive impairment by inhibiting mTOR-dependent autophagy in a CCH model.
-
AM 374
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM.
-
PDM2
PDM 2 is a potent and selective aryl hydrocarbon receptor (AhR) antagonist.
